Tag: licensing
-
Medical Robotics Company Crowdfunding IPO
A medical robotics company spun-off from labs at MIT is issuing its initial public stock offering through equity crowdfunding, aiming to raise $15 million.
-
Allergan to Option Gene Editing for Eye Diseases
International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard.
-
Process Converts Food Waste to Auto Tire Materials
Agricultural scientists in Ohio are developing a process for converting common food waste into materials used in car tires, and filed a patent for these techniques.
-
Duchenne Gene-Editing Company Launched, Raising $5M
A biotechnology start-up is applying a process for editing-out disease-causing mutations to correct the inherited disorder Duchenne muscular dystrophy.
-
Patent Issued for Peptides in Diabetes Gene Therapy
A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure.
-
Patent Office Decides for Broad and Editas in Crispr Case
The U.S. Patent and Trademark Office decided that the gene editing processes developed by Broad Institute and licensed to Editas Medicine do not interfere with techniques for genome editing created by University of California at Berkeley.
-
Tissue Regeneration Start-Up Gains $33M in Early Funds
A new enterprise founded by researchers at Stanford University aims to discover and develop drugs that repair and regenerate tissue from stem cells.
-
Biotechs License Solid Tumor Therapy in $2.1B Deal
Biotechnology enterprise Immunomedics Inc. is licensing its enhanced antibody-based treatment for solid tumor cancers to Seattle Genetics, a developer of similar cancer drugs.
-
Trial Testing Artificial Pancreas for Type 1 Diabetes
A clinical trial testing day-to-day use of a smartphone-controlled artificial pancreas for people with type 1 diabetes began enrolling participants.
-
Univ. Spin-Off Offering Pediatric Care Software
A company spun-off from Indiana University is marketing software written in its medical school to relate pediatric clinical guidelines to parents’ concerns during office visits.